ASRV vs VRTX · P/E 14, rev $7.5M vs P/E 30, rev $3.33B
AmeriServ Financial Inc (ASRV) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
AmeriServ Financial Inc (ASRV) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US. It is led by Reshma Kewalramani FASN, M.D..
Latest reported ASRV revenue for 2026-06-30 was $7.5M. Net income was $4.5M. ASRV currently screens at market cap $50.7M and trailing P/E 14.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ASRV currently screens at market cap $50.7M and trailing P/E 14.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ASRV and VRTX stock pages for the full models.
Not investment advice.